# Preclinical evaluation of Lactiplantibacillus plantarum as a probiotic alternative against multidrug-resistant avian pathogenic Escherichia coli in chickens

**Authors:** Hanem El-Sharkawy, Ahmed Mohamed Abdelsalam, Mohamed Marzok, Yamen Hegazy, Hussein Babiker, Amin Tahoun

PMC · DOI: 10.3389/fimmu.2025.1640600 · Frontiers in Immunology · 2025-11-04

## TL;DR

This study evaluates Lactiplantibacillus plantarum as a probiotic to combat drug-resistant Escherichia coli in chickens, showing improved immunity and reduced infection.

## Contribution

Demonstrates the efficacy of L. plantarum ATS1 in reducing APEC colonization and mortality in broiler chickens.

## Key findings

- L. plantarum showed strong adhesion to epithelial cells and survival in macrophages.
- In vivo, it improved growth performance, increased IgY levels, and reduced APEC colonization and mortality.
- APEC isolates showed multidrug resistance, including resistance to cefixime and aztreonam.

## Abstract

Avian pathogenic Escherichia coli (APEC) is a leading cause of disease and mortality in broiler chickens, resulting in substantial economic losses. Probiotics such as Lactiplantibacillus plantarum (L. plantarum) have shown potential to enhance host immunity and limit pathogen colonization, but their efficacy against APEC is not fully understood.

One hundred diseased broilers from 20 farms were screened for E. coli isolation, serotyping, and antimicrobial resistance. The probiotic strain L. plantarum ATS1 (GenBank accession no. PV478081.1), previously isolated and partially characterized in our laboratory, was evaluated for adhesion to Caco-2 epithelial cells, survival in murine macrophages, and In Vivo effects on growth performance, serum IgY levels, and protection against oral challenge with APEC O126:K71 at 28 days of age.

Twenty-three E. coli isolates were recovered, with (APEC) predominating (80%) and 20% identified as Shiga toxin-producing O26 strains. Multidrug resistance was common, including complete resistance to cefixime and aztreonam. L. plantarum showed strong adhesion to epithelial cells (5.65 ± 1 bacteria/cell) and survived within macrophages. In Vivo supplementation increased serum IgY, improved body weight gain and feed conversion ratio, reduced cecal and hepatic APEC colonization, and lowered mortality following challenge.

L. plantarum ATS1 provides protective and immunomodulatory effects against APEC by supporting intestinal colonization, surviving in macrophages, and enhancing humoral immunity. These findings highlight its potential as a probiotic strategy to improve broiler health and reduce dependence on antibiotics.

## Linked entities

- **Chemicals:** cefixime (PubChem CID 5362065), aztreonam (PubChem CID 5742832)
- **Species:** Gallus gallus (taxon 9031), Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** weight gain (MESH:D015430)
- **Chemicals:** cefixime (MESH:D020682), aztreonam (MESH:D001398)
- **Species:** Otitesella sp. 26 (species) [taxon 257750], Gallus gallus (bantam, species) [taxon 9031], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Lactiplantibacillus plantarum (species) [taxon 1590]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12623324/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12623324/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12623324/full.md

---
Source: https://tomesphere.com/paper/PMC12623324